Head-To-Head Survey: Vivos (OTCMKTS:RDGL) versus Acutus Medical (NASDAQ:AFIB)

Vivos (OTCMKTS:RDGL) and Acutus Medical (NASDAQ:AFIB) are both small-cap finance companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, profitability, analyst recommendations, valuation, institutional ownership, dividends and risk.

Risk and Volatility

Vivos has a beta of 0.96, indicating that its stock price is 4% less volatile than the S&P 500. Comparatively, Acutus Medical has a beta of 0.04, indicating that its stock price is 96% less volatile than the S&P 500.

Profitability

This table compares Vivos and Acutus Medical’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Vivos	-9,524.89%	N/A	-201.99%
Acutus Medical	-166.79%	-54.97%	-13.82%

Analyst Recommendations

This is a summary of recent ratings and recommmendations for Vivos and Acutus Medical, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Vivos	0	0	0	0	N/A
Acutus Medical	0	0	0	0	N/A

Valuation & Earnings

This table compares Vivos and Acutus Medical’s top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Vivos	$20,000.00	4,435.02	-$2.89 million	($0.01)	-21.59
Acutus Medical	$7.16 million	0.20	-$81.66 million	N/A	N/A

Vivos has higher earnings, but lower revenue than Acutus Medical.

Insider & Institutional Ownership

56.9% of Acutus Medical shares are held by institutional investors. 18.5% of Vivos shares are held by company insiders. Comparatively, 5.2% of Acutus Medical shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Summary

Vivos beats Acutus Medical on 5 of the 9 factors compared between the two stocks.

About Vivos

Vivos Inc., a radiation oncology medical device company, develops brachytherapy devices for the treatment of non-resectable tumors in the United States. It develops yttrium-90 based RadioGel device, an injectable particle-gel for brachytherapy radiation treatment of cancerous tumors in people and animals; and IsoPet for the treatment of solid tumors in animals. The company was formerly known as Advanced Medical Isotope Corporation and changed its name to Vivos Inc. in December 2017. Vivos Inc. was incorporated in 1994 and is headquartered in Richland, Washington.

About Acutus Medical

Acutus Medical, Inc. designs, manufactures, and markets various tools for catheter-based ablation procedures to treat various arrhythmias in the United States and internationally. Its product portfolio includes novel access sheaths, transseptal crossing tools, diagnostic and mapping catheters, conventional and contact ablation catheters, and mapping and imaging consoles and accessories, as well as supporting algorithms and software programs. Acutus Medical, Inc. was incorporated in 2011 and is headquartered in Carlsbad, California.